Literature DB >> 7983357

Quantitation of P450 aromatase immunoreactivity in human ovary during the menstrual cycle: relationship between the enzyme activity and immunointensity.

T Suzuki1, H Sasano, H Sasaki, T Fukaya, H Nagura.   

Abstract

To understand changes associated with the menstrual cycle in the human ovary, it is very important to examine chronological changes in P450 aromatase (P450arom) enzymatic activity in the normal cycling ovary. Therefore, we initially examined the correlation between intensity of P450arom immunoreactivity and its biochemical enzymatic activity in five estrogen-producing human cancer cell lines (HHUA, Ishikawa, HEC-59, OMC-2, and MCF-7). P450arom immunointensity per cell was evaluated by the CAS 200 computed image analysis system, and its catalytic activity per 10(6) culture cells was analyzed by the tritiated water method. A significant correlation (r = 0.959) was demonstrated between P450arom immunoreactivity and enzymatic activity under optimal conditions of tissue fixation and immunohistochemical procedures. We then investigated P450arom immunointensity in 31 specimens of normal cycling human ovaries to examine chronological changes in P450arom activity per cell throughout the menstrual cycle. In the follicular phase, P450arom was observed in the granulosa cells of one selected antral follicle per case during the mid- to late proliferative period, and its immunointensity per granulosa cell in the follicle was not significantly different between mid- and late proliferative periods, although serum estradiol level was markedly elevated in the late proliferative period. In the luteal phase, both P450arom immunointensity per luteinized granulosa cell in a corpus luteum and serum estradiol level reached a peak in the mid-secretory period. These findings indicate that different factors may influence ovarian P450arom activity during the follicular and luteal phases, i.e., an increased number of granulosa cells in the selected follicle during the follicular phase but changes in P450arom activity per luteinized granulosa cell in the corpus luteum during the luteal phase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7983357     DOI: 10.1177/42.12.7983357

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  7 in total

1.  Localization of the aromatase enzyme expression in the human pituitary gland and its effect on growth hormone, prolactin, and thyroid stimulating hormone axis.

Authors:  Asli Sezgin Caglar; Aysegul Kapucu; Kadriye Akgun Dar; Hande Mefkure Ozkaya; Erkan Caglar; Haluk Ince; Pinar Kadioglu
Journal:  Endocrine       Date:  2015-02-20       Impact factor: 3.633

2.  Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas.

Authors:  Hande Mefkure Ozkaya; Nil Comunoglu; Fatma Ela Keskin; Buge Oz; Ozlem Asmaz Haliloglu; Necmettin Tanriover; Nurperi Gazioglu; Pinar Kadioglu
Journal:  Endocrine       Date:  2015-11-17       Impact factor: 3.633

3.  Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies.

Authors:  K Watanabe; H Sasano; N Harada; M Ozaki; H Niikura; S Sato; A Yajima
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

4.  Aromatase in human common epithelial ovarian neoplasms.

Authors:  K Kaga; H Sasano; N Harada; M Ozaki; S Sato; A Yajima
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

5.  Paternal Retrieval Behavior Regulated by Brain Estrogen Synthetase (Aromatase) in Mouse Sires that Engage in Communicative Interactions with Pairmates.

Authors:  Shirin Akther; Zhiqi Huang; Mingkun Liang; Jing Zhong; Azam A K M Fakhrul; Teruko Yuhi; Olga Lopatina; Alla B Salmina; Shigeru Yokoyama; Chiharu Higashida; Takahiro Tsuji; Mie Matsuo; Haruhiro Higashida
Journal:  Front Neurosci       Date:  2015-12-15       Impact factor: 4.677

6.  A novel action of follicle-stimulating hormone in the ovary promotes estradiol production without inducing excessive follicular growth before puberty.

Authors:  Charlotte M François; Florence Petit; Frank Giton; Alain Gougeon; Célia Ravel; Solange Magre; Joëlle Cohen-Tannoudji; Céline J Guigon
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

7.  Intratumoral concentration of estrogens and clinicopathological changes in ductal carcinoma in situ following aromatase inhibitor letrozole treatment.

Authors:  K Takagi; T Ishida; Y Miki; H Hirakawa; Y Kakugawa; G Amano; A Ebata; N Mori; Y Nakamura; M Watanabe; M Amari; N Ohuchi; H Sasano; T Suzuki
Journal:  Br J Cancer       Date:  2013-06-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.